PMF, ET, RARS-T, and 5q- syndrome. The World Health Organization classification, the mutational landscape, and the distinctive clinical and morphologic features for the 4 malignant diseases are described. The schematic representation of megakaryocyte morphology, as a hallmark distinctive of PMF, ET, RARS-T, and 5q- syndrome, is shown at the bottom of the figure.